- Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
2024/08/19 by Teena Bhatla, Laura E. Hogan, Laura Hogan +32 · 17 citations
Medicine · #Acute Lymphoblastic Leukemia research #Acute lymphocytic leukemia #Childhood Cancer Survivors' Quality of Life #Chronic Myeloid Leukemia Treatments #Daratumumab #Gastroenterology #Hematopoietic stem cell transplantation #Immune system #Immunology #Internal medicine #Lenalidomide #Leukemia #Lymphoblastic Leukemia #Lymphoblastic lymphoma #Lymphoma #Medicine #Minimal residual disease #Multiple myeloma #Oncology #T cell #Transplantation
- Results from Lummicar-2: A Phase 1b/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Patients with Relapsed and/or Refractory Multiple Myeloma
2020/11/04 by Shaji K. Kumar, Shaji Kumar, Rachid Baz +13 · 25 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Antigen #Biology #CAR-T cell therapy research #Cancer research #Chimeric antigen receptor #Immune system #Immunology #Insect Resistance and Genetics #Internal medicine #Lenalidomide #Medicine #Multiple Myeloma Research and Treatments #Multiple myeloma #Refractory (planetary science) #T cell